CD82 and prostate carcinoma: In conclusion, our study provides evidence that SFMBT2 regulates prostate cancer metastasis either by direct repression of YY1 target genes such as MMP-9, MMP-26, and N-CoR and by indirect regulation of MMP-2, MMP-3, and KAI1 gene expression.